Влияние недавних изменений в GVP ЕАЭС
January 21, 2025
Inpharmatis Team COVID-19 Update
We are taking all necessary measures to reduce the spread of the COVID-19 virus. The safety of our clients, partners and employees is our priority. Therefore, we have canceled all personal meetings and planned training courses. Due to the COVID-19 expansion geographically, also most GMP inspections have been suspended, traveling limited and a lot of companies begin teleworking. |
Our team is continuing to work remotely, and available in normal working hours to support you during this difficult time as best as possible. |
We value and respect our client’s business and are committed to delivering results by knowledgeable focus, meeting deadlines and professional project management despite the global COVID-19 situation. |
Our team of highly experienced experts is highly committed to supporting you during this difficult time as best as possible by continuing to provide full pharmaceutical product life-cycle management over the whole of EU & CIS in pharmacovigilance, regulatory affairs, medical writing, market access services and a range of specific software to the pharmaceutical industry. |
To maintain our client’s business continuity, we are delighted also to propose comprehensive and detailed GMP audit reports of active pharmaceutical ingredients (API) manufacturers performed by Inpharmatis. |
Schedule with us virtual meetings and find out how can we help you. Please email your request to info@inpharmatis.com or call us +371 6721 0500. |
Our CEO Dr. P.Dombure is reminding and repeatedly advising all employees, clients, and partners to practice a social distancing and take all proper hygiene steps thus reducing the risk of infection or spreading the infection to others. |
Stay strong and healthy! |
Kind regards, |
Inpharmatis team |


Impact of Recent Changes in EAEU GVP
January 21, 2025
Новые правила оплаты регистрации лекарственных средств и медицинских изделий в Узбекистане
December 03, 2024
New Payment Rules for Medicines and Medical Device Registration in Uzbekistan
December 03, 2024
Inpharmatis открыла юридическое лицо в Узбекистане
November 28, 2024
Inpharmatis Opens an LLC Legal Entity in Uzbekistan
November 28, 2024
Полина Домбуре, генеральный директор Inpharmatis Group, выступит спикером на вебинаре, организованном TOPRA
October 16, 2024
Dr. Polina Dombure to Speak at TOPRA Webinar "Navigating Regulatory Changes in Moldova and Ukraine"
October 16, 2024
Полина Домбуре, генеральный директор Inpharmatis Group, примет участие в CPHI Milan 8-10 октября 2024
September 25, 2024
Dr. Polina Dombure, CEO of Inpharmatis Group, will be attending CPHI Milan in 8-10 October 2024
September 25, 2024